Log In
BCIQ
Print this Print this
 

anetumab ravtansine (BAY 94-9343)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionAntibody-drug conjugate (ADC) composed of a human HuCAL IgG1 mAb targeting mesothelin conjugated to the maytansinoid tubulin inhibitor DMR
Molecular Target Mesothelin
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today